Project: Challenging African Swine Fever outbreaks with innovative VLP-based vaccines
| Acronym | ASF-INNOVAC (Reference Number: 114258) |
| Duration | 01/10/2020 - 01/10/2023 |
| Project Topic | We will develop a safe and effective vaccine against African Swine Fever Virus (ASFV) to provide a solution to the spread of this lethal virus. Here, we will combine the power of big data analysis and Artificial Intelligence (AI) with our innovative virus-like particles (VLPs) vaccine platform to identify the right antigens and deliver proof of concept vaccine candidates for the circulating ASFV variant. This approach will pave the way to develop vaccines for other viruses in the future. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 13 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Biomedical Research and Study Centre | Partner | Latvia |
| 2 | BISC Global | Partner | Belgium |
| 3 | Saiba Animal Health AG | Coordinator | Switzerland |
| 4 | The Institute of Virology and Immunology | Partner | Switzerland |